BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25103190)

  • 21. Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT): Patient Characteristics, Treatment, and Outcome-A Systematic Review.
    Wens FSPL; Hulsker CCC; Fiocco M; Zsiros J; Smetsers SE; de Krijger RR; van der Steeg AFW; Zweemer RP; Baas IO; Roes EM; Looijenga LHJ; Gerestein CG; Mavinkurve-Groothuis AMC
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT).
    Ramos P; Karnezis AN; Hendricks WP; Wang Y; Tembe W; Zismann VL; Legendre C; Liang WS; Russell ML; Craig DW; Farley JH; Monk BJ; Anthony SP; Sekulic A; Cunliffe HE; Huntsman DG; Trent JM
    Rare Dis; 2014; 2(1):e967148. PubMed ID: 26942101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type.
    Witkowski L; Goudie C; Ramos P; Boshari T; Brunet JS; Karnezis AN; Longy M; Knost JA; Saloustros E; McCluggage WG; Stewart CJR; Hendricks WPD; Cunliffe H; Huntsman DG; Pautier P; Levine DA; Trent JM; Berchuck A; Hasselblatt M; Foulkes WD
    Gynecol Oncol; 2016 Jun; 141(3):454-460. PubMed ID: 26975901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Small cell carcinoma of ovary, hypercalcemic type: analysis of clinicopathologic characteristics and the diagnostic utility of loss expression of SMARCA4 protein].
    Wang L; Tan C; Tu X; Zhang Y; Li X; Chang B
    Zhonghua Bing Li Xue Za Zhi; 2015 Dec; 44(12):859-63. PubMed ID: 26888501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SMARCA4 inactivating mutations cause concomitant Coffin-Siris syndrome, microphthalmia and small-cell carcinoma of the ovary hypercalcaemic type.
    Errichiello E; Mustafa N; Vetro A; Notarangelo LD; de Jonge H; Rinaldi B; Vergani D; Giglio SR; Morbini P; Zuffardi O
    J Pathol; 2017 Sep; 243(1):9-15. PubMed ID: 28608987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small-Cell Carcinoma of the Ovary of Hypercalcemic Type (Malignant Rhabdoid Tumor of the Ovary): A Review with Recent Developments on Pathogenesis.
    Witkowski L; Goudie C; Foulkes WD; McCluggage WG
    Surg Pathol Clin; 2016 Jun; 9(2):215-26. PubMed ID: 27241105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Population-Based Study of Patients With Small Cell Carcinoma of the Ovary, Hypercalcemic Type, Encompassing a 30-Year Period.
    Blatnik A; Dragoš VŠ; Blatnik O; Stegel V; Klančar G; Novaković S; Drev P; Žagar T; Merlo S; Škof E; Bojadžiski MP; Strojnik K; Krajc M
    Arch Pathol Lab Med; 2024 Mar; 148(3):299-309. PubMed ID: 37270804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary.
    Xue Y; Meehan B; Macdonald E; Venneti S; Wang XQD; Witkowski L; Jelinic P; Kong T; Martinez D; Morin G; Firlit M; Abedini A; Johnson RM; Cencic R; Patibandla J; Chen H; Papadakis AI; Auguste A; de Rink I; Kerkhoven RM; Bertos N; Gotlieb WH; Clarke BA; Leary A; Witcher M; Guiot MC; Pelletier J; Dostie J; Park M; Judkins AR; Hass R; Levine DA; Rak J; Vanderhyden B; Foulkes WD; Huang S
    Nat Commun; 2019 Feb; 10(1):558. PubMed ID: 30718512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refractory Small Cell Carcinoma of the Ovary - Hypercalcemic Type (SCCOHT) Treated with Romidepsin and Topotecan: A Case Report and Review of the Literature.
    Rao V; Bauer F; Vredenburgh JJ
    Conn Med; 2016 Oct; 80(9):529-532. PubMed ID: 29772136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small cell carcinoma of the ovary of the hypercalcemic type (SCCOHT)--case report.
    Lubin J; Pawałowska M; Markowska A; Bielas A
    Eur J Gynaecol Oncol; 2015; 36(1):88-90. PubMed ID: 25872342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours.
    Genestie C; Blanc-Durand F; Auguste A; Pautier P; Dunant A; Scoazec JY; Gouy S; Morice P; Bentivegna E; Maulard A; LeFormal A; Devouassoux-Shisheboran M; Leary A
    Br J Cancer; 2020 Feb; 122(4):564-568. PubMed ID: 31844183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small cell ovarian carcinoma: genomic stability and responsiveness to therapeutics.
    Gamwell LF; Gambaro K; Merziotis M; Crane C; Arcand SL; Bourada V; Davis C; Squire JA; Huntsman DG; Tonin PN; Vanderhyden BC
    Orphanet J Rare Dis; 2013 Feb; 8():33. PubMed ID: 23433318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of preadolescents with small cell carcinoma of the ovary hypercalcemic type.
    Pressey JG; Kelly DR; Hawthorne HT
    J Pediatr Hematol Oncol; 2013 Oct; 35(7):566-9. PubMed ID: 23459374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An In-Depth Look at Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT): Clinical Implications from Recent Molecular Findings.
    Lu B; Shi H
    J Cancer; 2019; 10(1):223-237. PubMed ID: 30662543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy combined with targeted therapy in advanced small cell carcinoma of the ovary of hypercalcemic type: A case of overall survival lasting for over 5 years.
    Gao Y; Zang L; Ye Y; Ma F; Kang M; Zheng K; Kang Y; Wang H; Xu C
    Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 297():270-274. PubMed ID: 38604920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases.
    Witkowski L; Donini N; Byler-Dann R; Knost JA; Albrecht S; Berchuck A; McCluggage WG; Hasselblatt M; Foulkes WD
    Fam Cancer; 2017 Jul; 16(3):395-399. PubMed ID: 27866340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical, morphological and immunohistochemical evidence that small-cell carcinoma of the ovary of hypercalcaemic type (SCCOHT) may be a primitive germ-cell neoplasm.
    McCluggage WG; Witkowski L; Clarke BA; Foulkes WD
    Histopathology; 2017 Jun; 70(7):1147-1154. PubMed ID: 28130795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A rare case after in vitro fertilization (IVF).
    Ghazi A; Ayaz A; Hamid T; Farooq MU; Islam N
    Pak J Med Sci; 2017; 33(1):241-244. PubMed ID: 28367208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): Comprehensive management of a newly diagnosed young adult.
    Pressey JG; Dandoy CE; Pater LE; Sroga Rios J; Sisson R; Dasgupta R; Szabo S
    Gynecol Oncol; 2020 Sep; 158(3):538-546. PubMed ID: 32654763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small cell carcinoma of the ovary of hypercalcemic type: a case report.
    McDonald JM; Karabakhtsian RG; Pierce HH; Iocono JA; Desimone CP; Bayliff SL; Ueland FR
    J Pediatr Surg; 2012 Mar; 47(3):588-92. PubMed ID: 22424359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.